Study guide

9.1 Acute Pulmonary Embolism

AACN Cardiac Medicine Certification CMC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview and the CMC Test Plan

1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them

2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease

2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy

3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease

3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup

4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions

4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation

5 Chapter 5: Vascular Conditions and Vascular Interventions

5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications

6 Chapter 6: Shock States and Mechanical Circulatory Support

6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD

7 Chapter 7: Cardiac Procedures and Structural Heart Interventions

7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

8 Chapter 8: Cardiovascular Pharmacology

8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure

9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary

9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients

10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral

10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients

11 Chapter 11: Monitoring and Diagnostics

11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography

12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions

12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

9.1 Acute Pulmonary Embolism

Key Takeaways Explain This Topic AI

High-risk (massive) PE is defined by a systolic blood pressure under 90 mmHg for 15 minutes or more, a drop of 40 mmHg or more from baseline, vasopressor need, or cardiac arrest; intermediate-high risk is a normotensive patient with both RV dysfunction and an elevated troponin, carrying a 10-15% short-term mortality.

Sinus tachycardia is the most common ECG finding in PE, but T-wave inversion in V1-V4 is the most common specific sign of RV strain and is routinely misread as anterior ischemia; S1Q3T3 appears in only 10-20% of cases.

The age-adjusted D-dimer cutoff for patients over 50 is age x 10 ng/mL FEU, and D-dimer has no role when pretest probability is high.

Alteplase 100 mg IV over 2 hours is the standard systemic lytic regimen for high-risk PE; in cardiac arrest with suspected PE the dose is 50 mg IV push with CPR continued 60-90 minutes.

Intubation, positive-pressure ventilation and large fluid boluses can precipitate arrest in acute PE; the nurse anticipates norepinephrine before induction, 250 mL boluses at most, inhaled pulmonary vasodilators, and early PERT/ECMO activation.

Last updated: August 2026

Why Pulmonary Embolism Is a Cardiac-Unit Problem

Test-plan item II.A.1 sits inside Domain II (Non-Cardiovascular Conditions, 23% of the exam), and CMC writes it from the cardiac angle: acute pulmonary embolism (PE) kills through the right ventricle, not through the lung. Your patients are the ones who get it — the post-cardiac-catheterization patient on bedrest, the heart failure patient with low-output venous stasis, the atrial fibrillation patient whose anticoagulation was interrupted for a procedure, the patient with an indwelling central catheter or newly implanted device leads, and the post-arrest patient. The nurse who understands the right ventricular (RV) failure spiral is the one who recognizes deterioration before the arrest.

The RV Failure Spiral

Once thrombus obstructs roughly 30-50% of the pulmonary vascular bed, mechanical obstruction is amplified by hypoxic pulmonary vasoconstriction and by mediators released from activated platelets (serotonin, thromboxane A2, endothelin-1). Pulmonary vascular resistance (PVR) rises abruptly , and the sequence that follows is the whole of PE pathophysiology:

Acute rise in RV afterload. A previously normal, thin-walled RV (free wall 3-5 mm) cannot acutely generate a mean pulmonary artery pressure much above 40 mmHg. If the measured mean PA pressure is 55 mmHg in a patient who "just" developed PE, that RV has been chronically conditioned by something else.

RV dilation and rising wall tension. Tricuspid annular dilation produces functional tricuspid regurgitation, which further volume-loads the RV.

Interventricular septal shift toward the left ventricle (ventricular interdependence within the fixed pericardium) plus pericardial constraint.

LV underfilling — the left ventricle is not failing, it is empty. Stroke volume and systemic blood pressure fall.

Reduced RV coronary perfusion. The RV is normally perfused in both systole and diastole because RV systolic pressure is low. When RV pressure rises and aortic pressure falls, RV perfusion becomes diastole-dependent and the perfusion gradient collapses.

RV ischemia and infarction (this is the troponin release, not coronary occlusion), falling RV contractility, and a further drop in output. The terminal rhythm is pulseless electrical activity.

B-type natriuretic peptide rises from RV stretch; troponin rises from RV microinfarction. Both are prognostic markers, not diagnostic tests, and both drive risk stratification.

Risk Stratification Drives Everything

CMC will not ask you to choose a lytic. It will ask you to classify the patient, because classification determines monitoring intensity, unit placement, and what you escalate.

  • Class Hemodynamics RV dysfunction (echo/CT) Troponin / BNP sPESI Short-term mortality Typical disposition
  • Low-risk Normal blood pressure Absent Normal 0 Under 1% Ward or early/outpatient discharge on a DOAC

Intermediate-low (submassive) Normal blood pressure RV dysfunction or biomarker elevation, not both One abnormal 1 or more 2-5% Monitored bed, anticoagulation, serial assessment

Intermediate-high (submassive) Normal blood pressure RV dysfunction and elevated troponin Both abnormal 1 or more 10-15%, with 5-10% risk of hemodynamic decompensation ICU or step-down, PERT activation, rescue-lysis plan at the bedside

High-risk (massive) Sustained systolic BP under 90 mmHg for 15 minutes or more, a drop of 40 mmHg or more from baseline, vasopressor requirement, or cardiac arrest Present Usually elevated Not used 25-50% ICU, immediate reperfusion decision

The Pulmonary Embolism Severity Index (PESI) and its simplified form ( sPESI ) score clinical variables, not imaging. sPESI assigns one point each for age over 80, active cancer, chronic cardiopulmonary disease, heart rate 110/min or greater, systolic BP under 100 mmHg, and arterial oxygen saturation under 90%. A score of 0 identifies a low-risk patient who may be managed at home; a score of 1 or more means the patient is not low risk, but sPESI alone never establishes intermediate-high status — you still need the echo and the troponin.

Exam trap: a normotensive patient is not a stable patient. The intermediate-high-risk patient with a dilated RV and a positive troponin is the one who arrests at 3 a.m. Normal blood pressure in acute PE is maintained by intense sympathetic vasoconstriction; when it fails, it fails suddenly and completely.

Loading diagram... The right ventricular failure spiral in acute PE